[1] [2] It represents a novel class of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, making it the first dual incretin receptor agonist available in clinical practice
Specifically approved by the FDA, Mounjaro is intended to stabilize blood sugar levels for those diagnosed with type 2 diabetes
Given that retatrutide has no UK marketing authorisation, the concept of 'stacking' it with other agents is not supported by any current clinical protocol in the UK
Key Features Not customizable Include batch-specific information and official branding Provide highest safety and regulatory assurance Pharmacy Secondary Labels Pharmacies may add secondary labels containing patient-specific information, prescription numbers, dosage instructions, refill dates, and contact details
For this reason, these studies are evaluating high-risk patients with persistently elevated LDL, established ASCVD and/or heterozygous familial hypercholesterolemia